As February 2026 begins, the U.S. stock market has seen a robust start with major indices like the Dow Jones Industrial Average and S&P 500 showing significant gains, reflecting positive investor sentiment despite recent economic uncertainties such as government shutdowns and changes in Federal Reserve leadership. In this dynamic environment, identifying high-growth tech stocks requires careful consideration of factors such as innovation potential, adaptability to market shifts, and financial health to navigate both opportunities and challenges effectively.

Top 10 High Growth Tech Companies In The United States

Name	Revenue Growth	Earnings Growth	Growth Rating
Marker Therapeutics	62.86%	62.39%	★★★★★★
Palantir Technologies	26.25%	28.42%	★★★★★★
Reddit	22.05%	28.08%	★★★★★★
Procore Technologies	11.43%	60.07%	★★★★★☆
Workday	10.61%	28.20%	★★★★★☆
Sandisk	28.86%	45.57%	★★★★★★
Circle Internet Group	24.19%	85.43%	★★★★★☆
Viridian Therapeutics	46.35%	51.40%	★★★★★☆
Zscaler	15.85%	45.68%	★★★★★☆
Duos Technologies Group	53.76%	155.11%	★★★★★☆

Here's a peek at a few of the choices from the screener.

Palantir Technologies (PLTR)

Simply Wall St Growth Rating: ★★★★★★

Overview: Palantir Technologies Inc. develops software platforms that support intelligence agencies in counterterrorism efforts globally, with a market cap of $332.51 billion.

Operations: The company generates revenue by providing software platforms to intelligence agencies for counterterrorism operations across multiple countries, including the United States and the United Kingdom.

Palantir Technologies has demonstrated a robust growth trajectory, with its recent earnings report showcasing a significant year-over-year revenue increase to $1.41 billion from $827.52 million and net income soaring to $608.68 million from $79.01 million. This performance is underscored by strategic partnerships, such as the extended collaboration with Airbus for the Skywise platform, enhancing aerospace efficiency and safety, and a new alliance with Cognizant to integrate AI in healthcare operations. These initiatives not only reflect Palantir's deepening penetration in diverse industries but also align with its R&D commitment, positioning it well for sustained innovation and market competitiveness in high-stakes environments like aerospace and healthcare where data security and operational agility are paramount.

Stoke Therapeutics (STOK)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Stoke Therapeutics, Inc. is an early-stage biopharmaceutical company focused on developing treatments for severe genetic diseases by upregulating protein expression, with a market cap of approximately $1.83 billion.

Operations: Stoke Therapeutics focuses on developing treatments for severe genetic diseases, generating revenue primarily from its pharmaceuticals segment, which amounted to $205.63 million.

Stoke Therapeutics has shown promising growth, with its recent OSPREY study for STK-002 targeting Autosomal Dominant Optic Atrophy, a condition with no approved treatments. This innovation could significantly impact the biotech landscape by addressing unmet medical needs. Financially, Stoke's revenue is projected to grow at an annual rate of 25.9%, outpacing the U.S. market average of 10.3%. Additionally, its earnings are expected to surge by 27.1% annually, reflecting robust underlying business dynamics and a strong commitment to R&D which fuels these advancements.

MNTN (MNTN)

Simply Wall St Growth Rating: ★★★★★☆

Overview: MNTN, Inc. operates a technology platform focused on performance marketing for Connected TV, with a market cap of $601.90 million.

Operations: The company generates revenue primarily from its Internet Software & Services segment, amounting to $272.81 million. Its focus on performance marketing for Connected TV positions it within the technology sector.

MNTN's recent pivot towards profitability is underscored by a significant earnings leap, reporting a net income of $34.48 million for Q4 2025, contrasting sharply with a net loss the previous year. This turnaround is anchored in robust revenue growth forecasts—projected at 22.9% year-over-year for 2026, outpacing broader market trends significantly. Innovatively, MNTN's QuickFrame AI redefines video marketing efficiency and scalability, ensuring that MNTN remains at the forefront of tech innovation while expanding its market reach through strategic partnerships like that with Magnite to capture premium live content audiences—a move likely to bolster its competitive edge in the streaming domain.

Turning Ideas Into Actions

• Take a closer look at our US High Growth Tech and AI Stocks list of 73 companies by clicking here.
• Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.